Carboplatin

BCL2 apoptosis regulator ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32072678 The combination of artesunate and carboplatin exerts a synergistic anti-tumour effect on non-small cell lung cancer. 2020 Jun 1
2 32643899 Effect of carboplatin injection on Bcl-2 protein expression and apoptosis induction in Raji cells. 2020 Jul 9 3
3 31908478 miR-7 Reverses Breast Cancer Resistance To Chemotherapy By Targeting MRP1 And BCL2. 2019 1
4 29254147 Measurement of molecular biomarkers that predict the tumor response in estrogen receptor-positive breast cancers after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy. 2017 Nov 24 1
5 25716014 Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin. 2015 Nov 1
6 25837691 Investigating breast cancer cell behavior using tissue engineering scaffolds. 2015 1
7 26125273 Underlying mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in SKOV3 human ovarian cancer cells. 2015 2
8 24406249 The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells. 2014 Feb 15 1
9 22904681 Long-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancer. 2012 Jul 3
10 22961366 Carboplatin treatment of antiestrogen-resistant breast cancer cells. 2012 Nov 4
11 21169413 The molecular basis of synergism between carboplatin and ABT-737 therapy targeting ovarian carcinomas. 2011 Feb 1 1
12 20096282 Akt inhibitor enhances apoptotic effect of carboplatin on human epithelial ovarian carcinoma cell lines. 2010 Apr 25 1
13 18324624 Transient ectopic expression as a method to detect genes conferring drug resistance. 2008 Jun 1 1
14 17404015 Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. 2007 Jan 2
15 17568189 Cell cycle dependent antagonistic interactions between paclitaxel and carboplatin in combination therapy. 2007 Jul 1
16 18056200 The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin. 2007 Dec 1 1
17 15996812 DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells. 2006 May 18 1
18 15120608 Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells. 2004 May 28 2
19 15576332 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. 2004 Nov 3
20 12926551 Induction of caspase 3 and modulation of some apoptotic genes in human acute promyelocytic leukemia HL-60 cells by carboplatin with amifostine. 2003 Mar-Apr 1
21 11755820 Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines. 2002 Jan 1
22 12570053 BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin. 2002 Dec 1
23 11723237 Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells. 2001 Dec 1
24 9664115 The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. 1998 Aug 1